International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1200 participants.
Also called NCT06566183
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,200 participants
- Sponsor
- Registry
-
NCT06566183
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Brazil, India, Mexico, Poland, South Korea
- Registry status
- Suspended
Technical summary
Registry record NCT06566183. Randomized; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2030-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial
- Acronym
- ISCHEMIA-LVD
- Condition
- Coronary Artery Disease
- Condition
- Cognitive Impairment
- Condition
- Heart Failure
- Intervention (Procedure)
- Guideline-directed medical therapy (GDMT)
- Intervention (Procedure)
- Coronary artery bypass grafting (CABG (coronary artery bypass grafting))
- Intervention (Procedure)
- Percutaneous coronary intervention (PCI (percutaneous coronary intervention)).
- Lead sponsor
- NYU Langone Health
Record details
- Record id
cardio:ct-nct06566183- Content hash
e8bf342d5f87a3692f5145dad8f802805952b059d04da342f2faf7dcc854a649